Treatment with mANT2 shRNA enhances antitumor therapeutic effects induced by MUC1 DNA vaccination
about
Optimized construction of MUC1-VNTRn DNA vaccine and its anti-pancreatic cancer efficacyThe combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131MUC1-specific cytotoxic T lymphocytes in cancer therapy: induction and challenge.Evaluation of in vivo antitumor effects of ANT2 shRNA delivered using PEI and ultrasound with microbubbles.
P2860
Treatment with mANT2 shRNA enhances antitumor therapeutic effects induced by MUC1 DNA vaccination
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Treatment with mANT2 shRNA enh ...... nduced by MUC1 DNA vaccination
@ast
Treatment with mANT2 shRNA enh ...... nduced by MUC1 DNA vaccination
@en
Treatment with mANT2 shRNA enh ...... nduced by MUC1 DNA vaccination
@nl
type
label
Treatment with mANT2 shRNA enh ...... nduced by MUC1 DNA vaccination
@ast
Treatment with mANT2 shRNA enh ...... nduced by MUC1 DNA vaccination
@en
Treatment with mANT2 shRNA enh ...... nduced by MUC1 DNA vaccination
@nl
prefLabel
Treatment with mANT2 shRNA enh ...... nduced by MUC1 DNA vaccination
@ast
Treatment with mANT2 shRNA enh ...... nduced by MUC1 DNA vaccination
@en
Treatment with mANT2 shRNA enh ...... nduced by MUC1 DNA vaccination
@nl
P2093
P2860
P356
P1433
P1476
Treatment with mANT2 shRNA enh ...... nduced by MUC1 DNA vaccination
@en
P2093
Chul-Woo Kim
Ji-Young Jang
June-Key Chung
Yong H Jeon
P2860
P304
P356
10.1038/MT.2010.235
P577
2010-11-09T00:00:00Z